Discovery Labs (DSCO) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data cuts rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial Results
August 10, 2015 4:45 PM EDTWARRINGTON, Pa., Aug. 10, 2015 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today provided a corporate update, and announced financial results for the second quarter ended June 30, 2015. The Company will host a conference call Tuesday August 11, 2015 at 8:30 AM ET. Conference call details are below.
Key Highlights
In the second quarter of 2015, the Company implemented a plan to focus its resources on the development of its aerosolized KL4 surfactant for respiratory diseases, beginning with AEROSURF® for respiratory distress syndrome... More
